What is the Mediwound Ltd. stock price forecast?

Mediwound Ltd. is currently trading at $16.63. View real-time AI analysis on Alpha Lenz.

What is Mediwound Ltd. insider trading activity?

View the latest insider trading data for Mediwound Ltd. on Alpha Lenz.

What is Mediwound Ltd.'s P/E ratio?

Mediwound Ltd.'s P/E ratio is -5.5.

Mediwound Ltd.

NASDAQ · MDWD

$16.63

Ask about Mediwound Ltd.'s future dividend policy...

Alpha Chat Insight

“Mediwound Ltd. trades at a P/E of -5.5 (undervalued) with modest ROE of -96.3%.”

Ask for details →

Company Overview

Mediwound Ltd. is a biopharmaceutical company that specializes in developing, manufacturing, and commercializing novel therapeutics for wound care and tissue repair. The company focuses on bioactive debridement solutions, aiming to improve healing outcomes for patients with burns, chronic wounds, and other skin-related conditions. MediWound's lead product is an enzymatic debridement agent that facilitates the removal of dead tissue from burn wounds, thereby promoting natural healing. Operating within the healthcare sector, MediWound's innovative treatments have made significant contributions to medical interventions and improved patient care standards globally. Based in Israel, the company collaborates with international healthcare institutions and regulatory bodies to ensure the accessibility and effectiveness of its products in various markets.

Websitehttps://www.mediwound.com

SectorHealthcare

IndustryBiotechnology

Employees111

Company Statistics

FY 2024

Profile

$165.63MMarket Cap

$20.22MRevenue

0.00Shares Out

111Employees

Margins

13.03%Gross

-85.06%EBITDA

-95.85%Operating

-149.16%Pre-Tax

-149.46%Net

Valuation

-5.48P/E

5.32P/B

8.19EV/Sales

-9.48EV/EBITDA

-8.32P/FCF

Growth (CAGR)

-5.24%Rev 3Yr

-8.65%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-43.19%ROA

-96.33%ROE

-42.03%ROIC

Financial Health

$9.15MCash & Cash Equivalents

$33.19MNet Debt

135.92%Debt/Equity

N/AInterest Cov